Rbv Hcv published presentations and documents on DocSlides.
Randomisation. Open-label. W8. * Liver biopsy or ...
N = 12. N = 13. W24. W16. SOF + EBR + GZR + RBV. ...
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...
ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...
PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...
C-WORTHY Study Part C: . grazoprevir. . + . elba...
*. 1:1. Open-label. ≥ 18 years. HCV genotype ...
dans les génotypes 1b naïfs de traitement . (1)...
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
Department of Medicine. University of Toronto. Co...
D : . grazoprevir. . + . elbasvir. + RBV in ge...
Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...
+ . Grazoprevir. +/- Ribavirin in . Treatment-N...
SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...
N = 69. >. 18 years. Failure to SOF/VEL . or ...
X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...
SOF + SMV + RBV. SOF + SMV. Randomisation. 2 : 1 ...
* Liver biopsy or . Fibroscan. ≤. 12.5 . kPa....
B7AB8DW10--62712/0216U28411204- f-25189455DVReWbVT...
Duke University School of Medicine. Durham, North ...
Jeffry Florian, Ph.D.. Division of Pharmacometrics...
ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....
B290. The object of strategic analysis…. Explai...
SAPPHIRE-I. Phase 3. . Treatment. . Naïve. Fel...
+ DSV + RBV. No randomisation. Open-label. TOPAZ-...
. and Dasabuvir +/- . RBV in . GT1b. PEARL-II. P...
N = 100. W12. W24. Arm B: . compensated cirrhosis...
N = 45. N = 49. W24. W16. MK3. > . 18 years. H...
Design. Objective. SVR. 12. (HCV RNA < 25 IU/...
-. 0938 in GT 1-4. QUANTUM. Phase . 2b. Treatment...
18-70 years. HCV genotype 1 or 3. Naïve or failu...
B290. The object of strategic analysis…. Explai...
(MK-1439; DOR). . NNRTI. Merck. Filed with USFDA...
(GSK-744; CAB). For . PrEP. INI. ViiV. Topical mi...
W24. SOF/VEL. >. 18 years. Chronic HCV infect...
CC By 010 Therapeutic Challenges College of Pharma...
Goals of the diagnosis survey. Measuring the . tim...
SOLAR-2. Source: . Manns. M, et al. Lancet Infect...
Copyright © 2025 DocSlides. All Rights Reserved